Advertisement

Molecular and Cellular Biochemistry

, Volume 365, Issue 1–2, pp 351–361 | Cite as

Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury

  • Ismail Syed
  • Jasmine Rathod
  • Mayur Parmar
  • George B. Corcoran
  • Sidhartha D. RayEmail author
Article

Abstract

Treatment during early tumor development has greater success because tissue growth remains largely confined to its original locus. At later stages, malignant cells migrate from their original location, invade surrounding normal areas, and can disseminate widely throughout the body. Remodeling of the extracellular matrix (ECM) serves as a key facilitator of this dissemination. Proteolytic enzymes including plasmin and matrix metalloproteinases (MMPs) play an integral role in degrading the surrounding ECM proteins and clearing a path for tumor cell migration. Specific MMPs are highly expressed late during malignant tumor invasion. It is not understood whether early changes in MMPs influence apoptotic and necrotic cell death, processes known to govern the early stages of carcinogenesis. Similarly, the interaction between MDM2 and p53 is tightly controlled by a complex array of post-translational modifications, which in turn dictates the stability and activity of both p53 and MDM2. The present studies examine the hypothesis that model hepatotoxin dimethylnitrosamine (DMN), which is also a model carcinogen, will induce the MMP family of proteins after administration in hepatotoxic doses. Doses of 25, 50, and 100 mg/kg DMN were administered i.p. to male C3H mice. Changes in parameters associated with apoptotic and necrotic cell death, DNA damage, cell proliferation, and extracellular proteinases were examined in liver at 24 h. Serum ALT activity, oxidative stress [malondialdehyde], and caspase-activated DNAse mediated DNA laddering increased in a dose-dependent manner, as did the level of MDM2 protein. MMP-9, -10 and -12 (gelatinase-B, stromelysin-2, macrophage elastase), and p53 protein levels increased following 25 mg/kg DMN, but were successively decreased after higher DMN doses. The results of this study demonstrate changes in MDM2 and MMPs during DMN-induced acute liver injury and provide a plausible linkage between DMN-induced oxidative stress-mediated genomic injury and its likely involvement in setting the stage for initiating subsequent metastatic disease at later circumstances.

Keywords

Oxidative stress Apoptosis Necrosis Dimethylnitrosamine Extracellular matrix Matrix metalloproteinases MDM2 Hepatotoxicity PCNA P53 

Notes

Acknowledgments

This study was supported by the Division of Pharmaceutical Sciences, AMS College of Pharmacy and Health Sciences, NY. Assistance provided by Ms. Dottie Young during the preparation of this manuscript is gratefully acknowledged. Animals used in this study was a generous gift by the Dean Dr. David Taft. This work was presented at the Annual meeting of the Society of Toxicology, 2007.

References

  1. 1.
    Magee P (1956) Toxic liver injury; the metabolism of dimethylnitrosamine. Biochem J 68:676–682Google Scholar
  2. 2.
    Ray SD, Sorge CL, Kamendulis LM, Corcoran GB (1992) Ca2+-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca2+-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice. J Pharmacol Exp Ther 263:387–394PubMedGoogle Scholar
  3. 3.
    Ray SD, Lam TS, Rotollo JA, Phadke S, Patel C, Dontabhaktuni A et al (2004) Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: implications of natural antioxidants in vivo. BioFactors 21:223–232PubMedCrossRefGoogle Scholar
  4. 4.
    Ray SD, Parikh H, Bagchi D (2005) Proanthocyanidin exposure to B6C3F1 mice significantly attenuates dimethylnitrosamine-induced liver tumor induction and mortality by differentially modulating programmed and unprogrammed cell deaths. Mutat Res 579:81–106PubMedCrossRefGoogle Scholar
  5. 5.
    Mirvish SS, Kaufman L (2008) A study of nitrosamines and S-carboxyl derivatives of cysteine as lung carcinogens in adult SWR mice. Int J Cancer 6:69–73CrossRefGoogle Scholar
  6. 6.
    Fong LY, Lin HJ, Lee CH (1979) Methylation of DNA in target and non-target organs of the rat with methylbenzylnitrosamine and dimethylnitrosamine. Int J Cancer 23:679–682PubMedCrossRefGoogle Scholar
  7. 7.
    Engelse LD, Oomen LC, Valk V, Hart AA, Dux A, Emmelot P (1981) Studies on lung tumours. V. Susceptibility of mice to dimethylnitrosamine-induced tumour formation in relation to H-2 haplotype. Int J Cancer 28:199–208CrossRefGoogle Scholar
  8. 8.
    Meier-Batschi A, Lutz WK, Schlatter C (1983) Methylation of liver DNA of rat and mouse by N-nitrosodimethylamine formed in vivo from dimethylamine and nitrite. Food Chem Toxicol 21:285–289CrossRefGoogle Scholar
  9. 9.
    Iqbal ZM, Dhal K, Epstein SS (1981) Biosynthesis of dimethylnitrosamines in dimethylamine-treated mice after exposure to nitrogen dioxide. J Natl Cancer Inst 67:137–141PubMedGoogle Scholar
  10. 10.
    Tomatis L, Magee PN, Shubik P (1964) Induction of liver tumors in the Syrian golden hamster by feeding dimethylnitrosamine. J Nat Cancer Inst 33:341–345PubMedGoogle Scholar
  11. 11.
    Suzuki T, Itoh T, Hayashi M, Nishikawa Y, Ikezaki S, Furukawa F et al (1996) Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice. Environ Mol Mutagen 28:348–353PubMedCrossRefGoogle Scholar
  12. 12.
    Khodos I, Ray SD (2009) Exposure to a proanthocynidin mixture significantly reduces dimethylnitrosamine (DMN)-induced nephrocarcinogenesis in vivo (abstract). Toxicologist 108:S163Google Scholar
  13. 13.
    Guttenplan JB (1993) Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine. Carcinogenesis 14:1013–1019PubMedCrossRefGoogle Scholar
  14. 14.
    Pritchard DJ, Butler WH (1989) Apoptosis—the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J Pathol 158:253–260PubMedCrossRefGoogle Scholar
  15. 15.
    Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB (1993) Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 7:453–463PubMedGoogle Scholar
  16. 16.
    Ray SD, Jena N (2000) A hepatotoxic dose of acetaminophen modulates expression of Bcl-2, Bcl-xL, and Bcl-xS during apoptotic and necrotic death of mouse liver cells in vivo. Arch Toxicol 73:594–606PubMedCrossRefGoogle Scholar
  17. 17.
    Kamendulis LM, Corcoran GB (1995) Dimethylnitrosamine-induced DNA damage and toxic cell death in cultured mouse hepatocytes. J Toxicol Environ Health 46:31–46PubMedCrossRefGoogle Scholar
  18. 18.
    Kamendulis LM, Corcoran GB (1994) DNA as a critical target in toxic cell death: enhancement of dimethylnitrosamine cytotoxicity by DNA repair inhibitors. J Pharmacol Exp Ther 271:1695–1698PubMedGoogle Scholar
  19. 19.
    Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB (1973) Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187:185–194PubMedGoogle Scholar
  20. 20.
    Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC (1980) Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol 18:536–542PubMedGoogle Scholar
  21. 21.
    Ray SD, Mumaw VR, Raje RR, Fariss MW (1996) Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther 279:1470–1483PubMedGoogle Scholar
  22. 22.
    Ray SD, Balasubramanian G, Bagchi D, Reddy CS (2001) Ca2+-calmodulin antagonist chlorpromazine and poly(ADP-ribose)polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of Bcl-xL and p53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice. Free Rad Biol Med 31:277–291PubMedCrossRefGoogle Scholar
  23. 23.
    Ray SD, Patel N, Shah N, Nagori A, Naqvi A, Stohs SJ (2006) Pre-exposure to a novel nutritional mixture containing a series of phytochemicals prevents acetaminophen-induced programmed and unprogrammed cell deaths by enhancing Bcl-xL expression and minimizing oxidative stress in the liver. Mol Cell Biochem 293:119–136PubMedCrossRefGoogle Scholar
  24. 24.
    Friedman MA, Watt KM, Higgins ES (1977) In vitro and in vivo effects of dimethylnitrosamine on mouse liver mitochondrial function. Proc Soc Exp Biol Med 154:530–533PubMedGoogle Scholar
  25. 25.
    Yamada K, Yamamiya I, Utsumi H (2006) In vivo detection of free radicals induced by diethylnitrosamine in rat liver tissue. Free Radic Biol Med 40:2040–2046PubMedCrossRefGoogle Scholar
  26. 26.
    Corcoran GB, Ray SD (1992) The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants. Toxicol Appl Pharmacol 113:167–183PubMedCrossRefGoogle Scholar
  27. 27.
    Horn TL, Bhattacharjee A, Schook LB, Rutherford MS (2000) Altered hepatic mRNA expression of apoptotic genes during dimethylnitrosamine exposure. Toxicol Sci 57:240–249PubMedCrossRefGoogle Scholar
  28. 28.
    Hsu YC, Chiu YT, Lee CL, Lin YL, Huang YT (2004) Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats. J Biomed Sci 11:408–417PubMedCrossRefGoogle Scholar
  29. 29.
    Cheng K, Ye Z, Guntaka RV, Mahato RI (2005) Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats. Mol Pharm 2:206–217PubMedCrossRefGoogle Scholar
  30. 30.
    Ismail S, Rathod J, Parmar M et al (2007) Modulation of expression of matrix metalloproteinases (MMPs -9, -10, & -12) during dimetylnitrosamine-induced liver cell death (abstract). Toxicologist 96:158Google Scholar
  31. 31.
    Rathod J, Ismail S, Parmar M et al (2007) Modulation of matrix metalloproteinases (MMPs) and MDM2 during acute dimethylnitrosamine (DMN)-induced nephrotoxicity in mice (Abstract). FASEB J 21(730):2Google Scholar
  32. 32.
    Lin HL, Parsels LA, Maybaum J, Hollenberg PF (1999) N-Nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P4502E1: evidence for apoptotic cell death. Toxicol Appl Pharmacol 157:117–124PubMedCrossRefGoogle Scholar
  33. 33.
    Jin YL, Enzan H, Kuroda N, Hayashi Y, Toi M, Miyazaki E et al (2006) Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine. Med Mol Morphol 33:33–43CrossRefGoogle Scholar
  34. 34.
    Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532–535PubMedCrossRefGoogle Scholar
  35. 35.
    Taverna D, Ullman-Culleré M, Rayburn H, Bronson RT, Hynes RO (1998) A test of the role of α5 integrin/fibronectin interactions in tumorigenesis. Cancer Res 58:848–853PubMedGoogle Scholar
  36. 36.
    Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67PubMedCrossRefGoogle Scholar
  37. 37.
    Xu D, McKee CM, Cao Y, Ding Y, Kessler BM, Muschel RJ (2010) Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res 70:6988–6998PubMedCrossRefGoogle Scholar
  38. 38.
    Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C et al (2007) Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9:893–904PubMedCrossRefGoogle Scholar
  39. 39.
    Wroblewski F, Ladue JS (1955) Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: a preliminary report. Ann Intern Med 43:345–360PubMedGoogle Scholar
  40. 40.
    Patel N, Joseph C, Corcoran GB, Ray SD (2010) Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol 245:143–152PubMedCrossRefGoogle Scholar
  41. 41.
    Ray SD, Patel D, Wong V, Bagchi D (2000) In vivo protection of DNA damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and Doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol 107:137–166PubMedGoogle Scholar
  42. 42.
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRefGoogle Scholar
  43. 43.
    Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354PubMedCrossRefGoogle Scholar
  44. 44.
    Liebler DC, Guengerich FP (2005) Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov 4:410–420PubMedCrossRefGoogle Scholar
  45. 45.
    Hirata K, Ogata I, Ohta Y, Fujiwara K (1989) Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats. J Pathol 158:157–165PubMedCrossRefGoogle Scholar
  46. 46.
    Heissig B, Nishida C, Tashiro Y, Sato Y, Ishihara M, Ohki M et al (2010) Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histol Histopathol 25:765–770PubMedGoogle Scholar
  47. 47.
    Friese RS, Rao F, Khandrika S, Thomas B, Ziegler MG, Schmid-Schonbein GW (2009) Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens 31:521–533PubMedCrossRefGoogle Scholar
  48. 48.
    Cataldo DD, Gueders MM, Rocks N, Sounni NE, Evrard B, Bartsch P et al (2003) Pathogenic role of matrix metalloproteinases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteinase inhibitors. Cell Mol Biol 49:875–884PubMedGoogle Scholar
  49. 49.
    Zeng ZS, Guillem JG (1995) Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72:575–582PubMedCrossRefGoogle Scholar
  50. 50.
    Harty MW, Muratore CS, Papa EF, Gart MS, Ramm GA, Gregory SH et al (2010) Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers. Am J Pathol 176:1271–1281PubMedCrossRefGoogle Scholar
  51. 51.
    Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G (2000) Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 113:443–453PubMedGoogle Scholar
  52. 52.
    Ito Y, Abril ER, Bethea NW, McCuskey RS (2005) Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. Toxicol Sci 83:190–196PubMedCrossRefGoogle Scholar
  53. 53.
    Goetzenich A, Hatam N, Zernecke A, Weber C, Czarnotta T, Autschbach R et al (2009) Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig. J Heart Lung Transplant 28:1087–1093PubMedCrossRefGoogle Scholar
  54. 54.
    Lafleur M, Underwood JL, Rappolee DA et al (1996) Basement membrane and repair of injury to peripheral nerve—defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311–2326CrossRefGoogle Scholar
  55. 55.
    Swiderski RE, Dencoff JE, Floerchinger CS, Shapiro SD, Hunninghake GW (1998) Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol 152:821–828PubMedGoogle Scholar
  56. 56.
    Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152:729–741PubMedGoogle Scholar
  57. 57.
    Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201–210PubMedCrossRefGoogle Scholar
  58. 58.
    Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE (2006) Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 79:1348–1356PubMedCrossRefGoogle Scholar
  59. 59.
    Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J (2000) Amplification of IL-1β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa β and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 165:5788–5797PubMedGoogle Scholar
  60. 60.
    Iimuro Y, Nishio T, Morimoto T, Nitta T et al (2003) Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124:445–458PubMedCrossRefGoogle Scholar
  61. 61.
    Kanemura H, Iimuro Y, Takeuchi M, Ueki T, Hirano T, Horiguchi K et al (2008) Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Hepatol Res 38:930–939PubMedCrossRefGoogle Scholar
  62. 62.
    Wallace K, Burt AD, Wright MC (2008) Liver fibrosis. Biochem J 411:1–18PubMedCrossRefGoogle Scholar
  63. 63.
    Bellayr IH, Mu X, Li Y (2009) Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem 1:1095–1111PubMedCrossRefGoogle Scholar
  64. 64.
    Ray SD, Corcoran GB (2009) General and applied toxicology. In: Ballantyne B, Marrs T, Syversion T (eds) Cell death and apoptosis, 3rd edn. Wiley, New York, pp 248–312Google Scholar
  65. 65.
    Bulku E, Stohs SJ, Cicero L, Brooks T, Halley H, Ray SD (2012) Curcumin exposure in vivo modulates multiple pro-apoptotic and anti-apoptotic signaling pathways to antagonize acetaminophen-induced toxicity. Curr Neurovas Res 9:58–71CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2012

Authors and Affiliations

  • Ismail Syed
    • 1
  • Jasmine Rathod
    • 2
  • Mayur Parmar
    • 2
  • George B. Corcoran
    • 3
  • Sidhartha D. Ray
    • 2
    Email author
  1. 1.Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA
  2. 2.Division of Pharmaceutical SciencesManchester College school of PharmacyFort WayneUSA
  3. 3.Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health SciencesWayne State UniversityDetroitUSA

Personalised recommendations